MedTrace Logo

Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams

NCT02167009 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-09-10

No results posted yet for this study

Summary

Study to evaluate Prostate Artery Embolization for the treatment of lower urinary track symptoms due to Benign Prostatic Hyperplasia and Prostate Size Greater Than 90 Grams.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

DEVICE

Embosphere Microspheres

Embosphere Microspheres are indicated for use in embolization of arteriovenous malformations, hypervascular tumors, and symptomatic uterine fibroids.

Sponsors & Collaborators

  • Tampa General Hospital

    lead OTHER

Principal Investigators

  • Cliff Davis, MD · Tampa General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2020-05-31
Completion
2020-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02167009 on ClinicalTrials.gov